Avivo was one of five companies selected for funding under the Government of Canada’s Life Sciences Fund to advance dual-use innovations and strengthen Canada’s industrial capacity.
Category: Research Highlight
Could seaweed support healthier herds?
New research from the lab of GlycoNet investigator Wade Abbot finds cows have gut microbes that enable them to digest the sugars in seaweed.
GlycoNet-Supported Startup Synakis Announces Close of Oversubscribed Pre-Seed Round
The CAD $2.6 million pre-seed financing round included support from GlycoNet’s Kickstart Program.
From blood innovation to biodefence: Next-generation health solutions for soldiers and civilians
Dr. Warren Wakarchuk highlights how glycomics research supports national security on multiple fronts.
How sugars are shaping the future of medicine and agriculture
This article highlights some of the ways that Canadian researchers are using glycomics to drive medical breakthroughs and more sustainable
Sugar-based vaccine against bacterial diarrhea shows promise in Phase 1 trial
A step closer to a vaccine for Campylobacter jejuni, a major global cause of
diarrheal illness.
32nd International Carbohydrate Symposium
GlycoNet will be attending the 32nd International Carbohydrate Symposium (ICS 2026), taking place July 5–9, 2026, in Bratislava, Slovakia.
AdvanCell and GlycoNet-supported startup 48Hour Discovery announce collaboration and exclusive licensing agreement
48Hour Discovery partners with AdvanCell to advance a peptide-based Lead-212 radioligand therapy program for oncology.
Balloon-like particles help reveal hidden sugar signals in the immune system
GlycoNet researchers have tailored liposome probes to detect molecular cues often missed by standard tools, offering a clearer picture of how immune cells communicate.
New machine learning model reveals unexpected protein-sugar interactions
By predicting surprising interactions beyond its training data, the model opens paths to deeper insight into molecular behaviour within complex systems.